Literature DB >> 12459255

Phylogenetic comparison of the pre-mRNA adenosine deaminase ADAR2 genes and transcripts: conservation and diversity in editing site sequence and alternative splicing patterns.

D Slavov1, K Gardiner.   

Abstract

Adenosine deaminase that acts on RNA -2 (ADAR2) is a member of a family of vertebrate genes that encode adenosine (A)-to-inosine (I) RNA deaminases, enzymes that deaminate specific A residues in specific pre-mRNAs to produce I. Known substrates of ADAR2 include sites within the coding regions of pre-mRNAs of the ionotropic glutamate receptors, GluR2-6, and the serotonin receptor, 5HT2C. Mammalian ADAR2 expression is itself regulated by A-to-I editing and by several alternative splicing events. Because the biological consequences of ADAR2 function are significant, we have undertaken a phylogenetic comparison of these features. Here we report a comparison of cDNA sequences, genomic organization, editing site sequences and patterns of alternative splicing of ADAR2 genes from human, mouse, chicken, pufferfish and zebrafish. Coding sequences and intron/exon organization are highly conserved. All ADAR2 genes show evidence of transcript editing with required sequences and predicted secondary structures very highly conserved. Patterns and levels of editing and alternative splicing vary among organisms, and include novel N-terminal exons and splicing events.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12459255     DOI: 10.1016/s0378-1119(02)01016-8

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  22 in total

Review 1.  Activity regulation of adenosine deaminases acting on RNA (ADARs).

Authors:  Cesare Orlandi; Alessandro Barbon; Sergio Barlati
Journal:  Mol Neurobiol       Date:  2011-11-20       Impact factor: 5.590

Review 2.  Adenosine deaminases acting on RNA, RNA editing, and interferon action.

Authors:  Cyril X George; Zhenji Gan; Yong Liu; Charles E Samuel
Journal:  J Interferon Cytokine Res       Date:  2010-12-23       Impact factor: 2.607

3.  Altered RNA editing in mice lacking ADAR2 autoregulation.

Authors:  Yi Feng; Christopher L Sansam; Minati Singh; Ronald B Emeson
Journal:  Mol Cell Biol       Date:  2006-01       Impact factor: 4.272

Review 4.  ADARs: viruses and innate immunity.

Authors:  Charles E Samuel
Journal:  Curr Top Microbiol Immunol       Date:  2012       Impact factor: 4.291

5.  Splicing variants of ADAR2 and ADAR2-mediated RNA editing in glioma.

Authors:  Yao Fu; Xingli Zhao; Zhaohui Li; Jun Wei; Yu Tian
Journal:  Oncol Lett       Date:  2016-06-15       Impact factor: 2.967

6.  A novel tissue-specific alternatively spliced form of the A-to-I RNA editing enzyme ADAR2.

Authors:  Lily Agranat; Joseph Sperling; Ruth Sperling
Journal:  RNA Biol       Date:  2010-03-17       Impact factor: 4.652

Review 7.  Adenosine deaminases acting on RNA (ADARs) are both antiviral and proviral.

Authors:  Charles E Samuel
Journal:  Virology       Date:  2011-01-05       Impact factor: 3.616

8.  Calcium-permeable AMPA receptors containing Q/R-unedited GluR2 direct human neural progenitor cell differentiation to neurons.

Authors:  Nicholas P Whitney; Hui Peng; Nathan B Erdmann; Changhai Tian; Daniel T Monaghan; Jialin C Zheng
Journal:  FASEB J       Date:  2008-04-10       Impact factor: 5.191

Review 9.  Dynamic regulation of RNA editing of ion channels and receptors in the mammalian nervous system.

Authors:  Bao Zhen Tan; Hua Huang; Runyi Lam; Tuck Wah Soong
Journal:  Mol Brain       Date:  2009-05-29       Impact factor: 4.041

10.  Novel exon of mammalian ADAR2 extends open reading frame.

Authors:  Stefan Maas; Willemijn M Gommans
Journal:  PLoS One       Date:  2009-01-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.